AI-DRIVEN DRUG TARGET IDENTIFICATION IN NEURODEGENERATION: APPLICATIONS IN ALZHEIMER’S, PARKINSON’S, AND ALS RESEARCH. (2026). Global Conference on Medical and Health Sciences, 1(6), 709-721. http://www.econferencia.com/index.php/5/article/view/1216